Positions

Research Overview

  • Dr. Nandagopal’s primary clinic interest is interested in genitourinary (GU) malignancies. His research interests are in developing clinical trials for GU malignancies, and development of correlative and prognostic biomarkers.
  • Principal Investigator On

  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2019 - 2024
  • Private Grant  awarded by CALITHERA BIOSCIENCES INC 2019 - 2024
  • Private Grant  awarded by MEDIVATION, INC 2019 - 2020
  • Investigator On

  • Private Grant  awarded by ADURO BIOTECH, INC. 2019 - 2024
  • Private Grant  awarded by CALITHERA BIOSCIENCES INC 2019 - 2024
  • Private Grant  awarded by PUMA BIOTECHNOLOGY, INC. 2019 - 2024
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2019 - 2024
  • Private Grant  awarded by ASTRAZENECA AB 2018 - 2023
  • Private Grant  awarded by CLOVIS ONCOLOGY 2017 - 2022
  • Private Grant  awarded by CLOVIS ONCOLOGY 2017 - 2022
  • Alliance for Clinical Trials in Oncology Payment Agreement  awarded by MAYO CLINIC 2017 - 2020
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • Full Name

  • Lakshminarayanan Nandagopal